Azevedo-Pereira José Miguel, Pires David, Calado Marta, Mandal Manoj, Santos-Costa Quirina, Anes Elsa
Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
Center for Interdisciplinary Research in Health, Católica Medical School, Universidade Católica Portuguesa, Estrada Octávio Pato, 2635-631 Rio de Mouro, Portugal.
Microorganisms. 2023 Mar 27;11(4):853. doi: 10.3390/microorganisms11040853.
Human immunodeficiency virus (HIV) and (Mtb) are pathogens responsible for millions of new infections each year; together, they cause high morbidity and mortality worldwide. In addition, late-stage HIV infection increases the risk of developing tuberculosis (TB) by a factor of 20 in latently infected people, and even patients with controlled HIV infection on antiretroviral therapy (ART) have a fourfold increased risk of developing TB. Conversely, Mtb infection exacerbates HIV pathogenesis and increases the rate of AIDS progression. In this review, we discuss this reciprocal amplification of HIV/Mtb coinfection and how they influence each other's pathogenesis. Elucidating the infectious cofactors that impact on pathogenesis may open doors for the design of new potential therapeutic strategies to control disease progression, especially in contexts where vaccines or the sterile clearance of pathogens are not effectively available.
人类免疫缺陷病毒(HIV)和结核分枝杆菌(Mtb)是每年导致数百万新感染病例的病原体;它们共同在全球范围内造成了高发病率和高死亡率。此外,晚期HIV感染使潜伏感染者患结核病(TB)的风险增加20倍,即使接受抗逆转录病毒疗法(ART)且HIV感染得到控制的患者,患TB的风险也增加了四倍。相反,Mtb感染会加剧HIV发病机制并加快艾滋病进展速度。在本综述中,我们讨论了HIV/Mtb合并感染的这种相互放大作用,以及它们如何相互影响对方的发病机制。阐明影响发病机制的感染性辅助因子可能为设计控制疾病进展的新潜在治疗策略打开大门,特别是在无法有效获得疫苗或无法实现病原体无菌清除的情况下。